Bio-Works Technologies AB (publ) (NGM:BIOWKS)
Sweden · Delayed Price · Currency is SEK 3.300
0.00 (0.00%)
At close: Apr 9, 2026
Bio-Works Technologies AB Market Cap
Bio-Works Technologies AB has a market cap or net worth of 328.1 million as of April 10, 2026. Its market cap has increased by 171.56% in one year.
Market Cap
328.10M
Enterprise Value
293.17M
Revenue
63.11M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.30
Market Cap Chart
Since December 14, 2017, Bio-Works Technologies AB's market cap has increased from 241.45M to 328.10M, an increase of 35.89%. That is a compound annual growth rate of 3.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 9, 2026 | 328.10M | 27.49% |
| Dec 30, 2025 | 257.35M | 242.79% |
| Dec 30, 2024 | 75.08M | -72.87% |
| Dec 29, 2023 | 276.76M | -62.42% |
| Dec 30, 2022 | 736.44M | -23.21% |
| Dec 30, 2021 | 959.03M | 246.49% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 14, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| FluoGuide | 588.58M |
| Oncopeptides AB | 553.01M |
| Corline Biomedical AB | 418.78M |
| Ascelia Pharma AB | 366.65M |
| Sprint Bioscience AB | 311.27M |
| Mendus AB | 287.11M |
| Elicera Therapeutics AB | 275.68M |
| Intervacc AB | 274.35M |